Beam Therapeutics Inc. (BEAM) at a glance

Beam Therapeutics Inc. (BEAM) is a mid-cap Healthcare company. It trades at $24.12, with a -40.2% profit margin and revenue growth of 324.9%. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$24.12

Market cap

$2.99B

P/E ratio

n/a

Dividend yield

None

Beta

2.20

52-week range

$16.02 to $38.26